TG Therapeutics (TGTX) P/E (2011 - 2026)
TG Therapeutics (TGTX) P/E from Sep 30, 2011 to Jul 21, 2026. The TTM TG Therapeutics (TGTX) P/E is 18.14. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of TG Therapeutics (TGTX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 18.14 | +75.06% |
| 2025 | 10.36 | -94.85% |
| 2024 | 200.99 | -320.95% |
| 2023 | -90.97 | +1172.23% |
| 2022 | -7.15 | -8.14% |
| 2021 | -7.78 | -67.30% |
| 2020 | -23.81 | +22.02% |
| 2019 | -19.51 | +232.63% |
| 2018 | -5.87 | -47.51% |
| 2017 | -11.17 | +17.46% |
| 2016 | -9.51 | -69.26% |
| 2015 | -30.94 | +3.97% |
| 2014 | -29.76 | +424.45% |
| 2013 | -5.67 | -63.85% |
| 2012 | -15.70 | -93.64% |
| 2011 | -246.92 | N/A |
Comparison TG Therapeutics (TGTX) P/E with competitors
TG Therapeutics (TGTX) P/E is 18.14.